Tristetraprolin mediates anti-inflammatory effect of carbon monoxide against DSS-induced colitis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24586391.
- Also identified by DOI 10.1371/journal.pone.0088776 and PMC identifier 3929600.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Endogenous carbon monoxide (CO) exerts anti-inflammatory effects. Tristetraprolin (TTP) is known to destabilize pro-inflammatory transcripts. Here we found that exogenous CO enhanced the decay of TNF-α mRNA and suppressed TNF-α expression in LPS-activated macrophages from wild-type (WT) mice. However, TTP deficiency abrogated the effects of exogenous CO. While CO treatment prior to DSS administration in WT mice significantly reduced inflammatory cytokine levels and colitis, it failed to reduce the pro-inflammatory cytokine levels and colitis in TTP knockout (KO) mice. Our results demonstrate that TTP is a key factor mediating the anti-inflammatory action of CO in DSS-induced colitis.
Medical subject headings
- Anti-Inflammatory Agents
- Carbon Monoxide
- Colitis
- Dextran Sulfate
- Tristetraprolin